PDE4 inhibitor (investigational)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PDE4 inhibitor (investigational), covering 2019-01-28 to 2019-01-28. Get the full timeline:
Most recent: Clinical Trial Update: A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD [Phase 2]